TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Karo Pharma AS
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
677,353
|
517,067
|
388,418 |
Financial expenses |
9,784
|
5,017
|
4,881 |
Earnings before taxes |
133,417
|
143,498
|
102,810 |
Total assets |
402,851
|
388,149
|
269,551 |
Current assets |
357,695
|
340,361
|
215,352 |
Current liabilities |
246,085
|
228,590
|
141,820 |
Equity capital |
156,766
|
156,624
|
125,209 |
- share capital |
7,187
|
6,971
|
6,489 |
Employees (average) | 22 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
38.9%
|
40.4%
|
46.5% |
Turnover per employee | 17,655 | ||
Profit as a percentage of turnover |
19.7%
|
27.8%
|
26.5% |
Return on assets (ROA) |
35.5%
|
38.3%
|
40.0% |
Current ratio |
145.4%
|
148.9%
|
151.8% |
Return on equity (ROE) |
85.1%
|
91.6%
|
82.1% |
Change turnover |
144,265
|
99,821
|
-34,501 |
Change turnover % |
27%
|
24%
|
-8% |
Chg. No. of employees | 0 | ||
Chg. No. of employees % | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.